Filitra

Product Overview

Filitra is a prescription medication containing Vardenafil as its active component. As a phosphodiesterase type 5 (PDE5) inhibitor, it is clinically approved for the treatment of male erectile dysfunction (ED).

Uses

Filitra is indicated for the management of erectile dysfunction, a medical condition characterized by the inability to attain or sustain an erection sufficient for satisfactory sexual performance. The medication enhances penile blood circulation to facilitate erection during sexual stimulation.

How to Use

Administer Filitra orally, with or without meals. For optimal results, take the tablet approximately one hour prior to anticipated sexual activity. Strictly adhere to a maximum of one dose per 24-hour period.

Mechanism of Action

Vardenafil, the therapeutic agent in Filitra, functions by inhibiting PDE5 enzymes. This action promotes vasodilation of penile blood vessels, increasing blood flow to the corpus cavernosum and thereby enabling erection when combined with sexual arousal.

Dosage and Administration

The standard initial dosage is 10 mg, adjusted as needed. Based on individual response and tolerance, healthcare providers may recommend dosage adjustments ranging from 5 mg to the maximum approved dose of 20 mg. Always comply with your physician’s prescribed dosage regimen.

Benefits

Filitra provides clinically proven efficacy in treating ED, helping men achieve and sustain erections adequate for sexual intercourse. Proper usage may enhance sexual performance and improve overall sexual health outcomes.

Common Side Effects

Frequently reported adverse effects include cephalalgia (headache), vertigo, facial flushing, nasal congestion, and gastrointestinal discomfort. Persistent or severe symptoms warrant immediate medical consultation.

Important Warnings

Filitra is contraindicated with nitrate medications or nitric oxide donors due to the risk of potentially life-threatening hypotension. Exercise caution and consult your physician if you have cardiovascular conditions, hepatic/renal impairment, or concurrent medication use.

Storage Conditions

Maintain Filitra in a temperature-controlled environment (15-30°C), protected from humidity and light exposure. Ensure secure storage away from pediatric and pet access.

Disclaimer:

This content is intended for educational purposes only and represents expert-reviewed medical information. It should not substitute professional medical advice, diagnosis, or treatment. The complete safety profile, including potential drug interactions and contraindications, may not be fully detailed herein. Always consult your healthcare provider regarding medical conditions and treatment options. This information aims to complement, not replace, the physician-patient relationship.